GBS Benefits Revenue and Competitors

Location

N/A

Total Funding

Insurance

Industry

Estimated Revenue & Valuation

  • GBS Benefits's estimated annual revenue is currently $64.6M per year.(i)
  • GBS Benefits's estimated revenue per employee is $242,000

Employee Data

  • GBS Benefits has 267 Employees.(i)
  • GBS Benefits grew their employee count by 9% last year.

GBS Benefits's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
VPReveal Email/Phone
3
VPReveal Email/Phone
4
Head Commercial RelationshipsReveal Email/Phone
5
VP Retirement ServicesReveal Email/Phone
6
VP Employee ExperienceReveal Email/Phone
7
SVP OperationsReveal Email/Phone
8
Director Population HealthReveal Email/Phone
9
Medical DirectorReveal Email/Phone
10
Executive Administrative OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$120.2M43710%N/AN/A
#2
$7.6M435%N/AN/A
#3
$69.1M2923%$3.7MN/A
#4
$13.5M6810%N/AN/A
#5
$7.2M4132%N/AN/A
#6
$3.7M24-14%N/AN/A
#7
$8.1M465%N/AN/A
#8
$11.1M56-5%N/AN/A
#9
$13.3M670%N/AN/A
#10
$64.6M2679%N/AN/A
Add Company

What Is GBS Benefits?

We're not just any benefits consulting firm. We're GBS. We have nearly 30 years of experience in group benefits, a strong sense of purpose and it shows. At GBS, we don't stand still. We grow, we innovate, and we delight our clients. We are your neighbors and your friends in addition to being your partner in benefits. You'll see us at the store, at community events, and by your side as we navigate the complex terrain of insurance.

keywords:N/A

N/A

Total Funding

267

Number of Employees

$64.6M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GBS Benefits News

2022-04-19 - Invasive Group B strep in early infancy associated with higher risk of neurodevelopmental impairment in later life

The first multi-country study of its kind on GBS outcomes in low- and ... significant health benefits—in all regions of the world.

2022-04-17 - Risk for Guillain-Barré Syndrome Up After Ad.26.COV2.S ...

There were 36 confirmed cases of GBS after mRNA vaccines, ... review of the benefits and harms of aspirin in primary prevention of CVD.

2022-04-13 - Awake Prone Positioning No Benefit for COVID-19-Linked ...

TUESDAY, April 26, 2022 (HealthDay News) -- The incidence of Guillain-Barré syndrome (GBS) is increased after Ad.26.COV2.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$80.2M2705%N/A
#2
$68.9M276-7%N/A
#3
$82M2765%N/A
#4
$82.3M277N/AN/A
#5
$77.3M28028%N/A